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Chapter 6 
 
Cardiovascular 
 
Bioreactor system for tissue-engineered vascular construct 
Although tissue-engineered great vessels and heart valves are currently undergoing clinical 
trials in some institutions [1, 2], their routine clinical application is still underway. One 
major problem thwarting their wide clinical usage is lack of physical endurance, which 
limits their application to cardiovascular structures exposed to high systemic pressure. 
Although durable scaffold materials have been designed to resist such high pressure in vivo, 
these materials remain subject to degradation over a longer period, resulting in 
unsatisfactory outcomes after implantation. It is well known that cardiovascular cells such 
as endothelial or smooth muscle cells are influenced by their extracellular environment, 
especially local fluid dynamics. Numerous scientists have reported the effect of shear stress 
or stretch stress on both endothelial and vascular smooth muscle cells [3–5]. Bioreactors for 
cardiovascular conduits are designed to utilize the effects of those physical strains on the 
cells to create more optimal tissue for grafting. Although a biomimetic in vitro environment 
is known to increase the endurance of tissue-engineered cardiovascular components [6], the 
optimal culture conditions including various pressure profiles are not known for a 
bioreactor. It was our aim to design a bioreactor system that can reproduce a wide range of 
pulsatile flows with a completely physiological pressure profile. To develop this novel 
bioreactor system, an intra-aortic balloon pumping (IABP) system was combined with an 
outflow valve and a compliance chamber to obtain both physiological systolic and diastolic 
pressures. The compliance chamber and the resistant clamps were designed to reproduce a 
physiological and relatively wide pressure waveform instead of the original peaky 
waveform generated by the power source. With a computed manipulation system, this 
novel bioreactor allows adjustment over a varying range of pressures, pulse rates, and 
intervals. In this study, we also demonstrated the morphology and the biochemical 
properties of the tissue-engineered products to illustrate the practicality of this novel 
bioreactor system. Details of the bioreactor system are presented below. 
 
Bioreactor design 
Our bioreactor housing and tubing are made of acryl and polyvinyl chloride (PVC), respectively. 
The bioreactor is small enough to fit inside a standard CO2 incubator (Fig. 32), and the driving 
system is situated outside the incubator. The bioreactor consists of four chambers: a balloon 
chamber (1), a compliance chamber (2), a culture chamber (3), and a reservoir (4) (Fig. 33). The 
pressure generated by the IABP is conducted via the balloon (30 or 40 cm3), which is located 
inside the balloon chamber. The pulsatile flow is generated in the compliance chamber through a 
one-way outflow valve. The compliance chamber and the culture chamber are connected by a 
PVC tube with a clamp that controls the fluid flow and pressure. The tissue-engineered products 
are fabricated inside the culture chamber, which is connected to the reservoir via a PVC tube. A 
resistance clamp is located in the middle of the connection tube to regulate the afterload. The air 
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filter on the reservoir regulates the amount of CO2 in the atmosphere. Fluids recirculate back to 
the balloon chamber via one-way valve from the reservoir. This system is sterilized with ethylene 
oxide. Conditions in the culture chamber are monitored by a pressure meter and a flow meter, 
and are recorded by a computerized analyzer. 
 
 
Fig. 32. Schema of the pulse-duplicating bioreactor system. The bioreactor is small enough to 
fit inside a standard CO2 incubator, and the driving system is situated outside the incubator. 
The basal part of this bioreactor is the balloon chamber (1). Control of inflow to and outflow 
from the balloon chamber is by a mechanical valve. The compliance chamber (2) buffers the 
pumping flow and pressure. The engineered tissue sample is located in the culture chamber 
(3). A regulating clamp is placed between (2) and (3). The next chamber is the reservoir 
equipped with an air filter for a CO2 incubator (4). The air filter (*) regulates the amount of 
CO2 in the atmosphere. A resistance clamp between (3) and (4) regulates the afterload. 
Conditions in the culture chamber are monitored by a pressure meter and a flow meter, and 
are recorded by a computerized analyzer (From Narita et al. 2004. Reprinted with permission).  
 
Bioreactor function analyses 
After confirming the capability of this bioreactor system for flow, pressure, and frequency, 
we tried to evaluate the actual physical strains for the culture cells. First, the shear stress 
level (γ) in the scaffold was calculated as  
γ = μ × du/dr = 4μQ/πr3 
where μ is the viscosity of the culture medium, du/dr is the velocity gradient, Q is the flow 
rate of the bioreactor, and r is the radius of the scaffold under the physiological or peaky 
waveform pattern of pulsatile flow (with a mean flow rate of 500 ml/min and 40 mmHg of 
systolic pressure). Next, we estimated the uniaxial cyclic strain under pulsatile flow by 
∂ π π π
∂
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measuring the diameter change of the scaffold under various pressure conditions, using a 
specially designed system. The system consisted of a digital video camera, a pressure 
monitor, a flow meter, and an analyzing computer. Under various conditions, the outside 
diameter of the scaffold, which was mounted in the culture chamber, was recorded with a 
digital video camera. The images were downloaded to a computer and the diameter was 
measured with NIH Image software. With this system, the actual stretch of the scaffold 
(only the direction perpendicular to the axis of the scaffold) could be estimated as a change 
in the scaffold radius as follows:  
∂ = 100 × (πDmax - πDmin)/ πDmin 
where ∂ is the percentage of radial diameter change (which is equivalent to the change of 
scaffold length around the axis), Dmax is the maximum diameter, and Dmin is the 
minimum diameter of the scaffold. The sensitivity of the system was enough to detect a 
difference of more than 0.2%. 
 
(1) 
(3) (2) 
(4) 
 
Fig. 33. Experimental setting of the pulse-duplicating bioreactor. The bioreactor consists of 
four chambers: a balloon chamber (1), compliance chamber (2), culture chamber (3), and 
reservoir (4). Pulsatile flow is generated in the compliance chamber (2) through a one-way 
outflow valve. The compliance chamber (2) and the culture chamber (3) are connected by a 
PVC tube with a clamp that controls the fluid flow and pressure. Tissue-engineered 
products are fabricated inside the culture chamber (3), which is connected to the reservoir 
(4) via a PVC tube. Fluids recirculate back to the balloon chamber (1) via a one-way valve 
from the reservoir (4) (From Narita et al. 2004. Reprinted with permission).  
 
The combination of an outflow valve, compliance chamber, and resistant clamps together 
with a balloon pumping system was able to successfully reproduce both physiological 
systolic and diastolic pressures. The compliance chamber was especially effective in 
transforming the original peaky pressure waveform into a physiological pressure profile. 
The tissues, cultured under a physiological pressure waveform with pulsatile flow, 
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presented widely distributed cells in close contact with each other. They also showed 
significantly higher cell numbers, total protein content, and proteoglycan–glycosaminoglycan 
content than cultured tissues under a peaky pressure wave or under static conditions (Fig. 
34). This new bioreactor system is suitable for evaluating a favorable environment for 
tissue-engineered cardiovascular components. 
 
A 
B 
 
Fig. 34. Bright-field photomicrographs showing H-E staining of newly formed tissues under 
dynamic and static conditions. A: The tissues in group D-w were exposed to pressure with 
physiological wide-shaped waveforms for 7 days. B: Tissue in group S was maintained 
under static conditions. Note that cell density was clearly higher under dynamic conditions 
than under static conditions (Original magnification × 100) (From Narita et al. 2004. 
Reprinted with permission).  
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Tissue engineering, which aims at regenerating new tissues, as well as substituting lost organs by making use
of autogenic or allogenic cells in combination with biomaterials, is an emerging biomedical engineering field.
There are several driving forces that presently make tissue engineering very challenging and important: 1) the
limitations in biological functions of current artificial tissues and organs made from man-made materials alone,
2) the shortage of donor tissue and organs for organs transplantation, 3) recent remarkable advances in
regeneration mechanisms made by molecular biologists, as well as 4) achievements in modern biotechnology
for large-scale tissue culture and growth factor production. 
This book was edited by collecting all the achievement performed in the laboratory of oral and maxillofacial
surgery and it brings together the specific experiences of the scientific community in these experiences of our
scientific community in this field as well as the clinical experiences of the most renowned experts in the fields
from all over Nagoya University. The editors are especially proud of bringing together the leading biologists
and material scientists together with dentist, plastic surgeons, cardiovascular surgery and doctors of all
specialties from all department of the medical school of Nagoya University. Taken together, this unique
collection of world-wide expert achievement and experiences represents the current spectrum of possibilities in
tissue engineered substitution.
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